Connection

Michel Drancourt to Drug Therapy, Combination

Back to Details
This is a "connection" page, showing publications Michel Drancourt has written about Drug Therapy, Combination.
Michel Drancourt
Connection Strength
0.149
Drug Therapy, Combination
  1. SARS-CoV-2 Persistent Viral Shedding in the Context of Hydroxychloroquine-Azithromycin Treatment. Viruses. 2021 05 12; 13(5).
    View in: PubMed
    Score: 0.083
  2. Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France. Travel Med Infect Dis. 2020 May - Jun; 35:101738.
    View in: PubMed
    Score: 0.019
  3. Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study. Travel Med Infect Dis. 2020 Mar - Apr; 34:101663.
    View in: PubMed
    Score: 0.019
  4. Trends in the discovery of new drugs for Mycobacterium tuberculosis therapy with a glance at resistance. Tuberculosis (Edinb). 2018 03; 109:17-27.
    View in: PubMed
    Score: 0.016
  5. Ocular Whipple's disease: therapeutic strategy and long-term follow-up. Ophthalmology. 2012 Jul; 119(7):1465-9.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.